← Latest Filings
A

Albers Jeffrey W.

Open-market buys
0
$0 total
Open-market sells
6
$3.1M total
Tracking since
Oct 2025
Activity timeline
Open-market sale — $1.0M
Spyre Therapeutics, Inc. · Aug 7, 2026
Open-market sale — $835K
Spyre Therapeutics, Inc. · Aug 7, 2026
Open-market trades from the last two years.

4 more trades. A free account shows you more; Premium shows every one.

Log in
Holdings as last reported
45,000 Stock Option (Right to Buy) in SYRE
Held directly · as of 2026-08-07
9,360 Common Stock in SYRE
Held indirectly (By Sessions LLC) · as of 2026-08-07

3 more holdings. A free account shows you more; Premium shows every one.

Log in
Companies touched
Spyre Therapeutics, Inc.
CIK 0001636282
Kymera Therapeutics, Inc.
CIK 0001815442